<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="180222">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00748618</url>
  </required_header>
  <id_info>
    <org_study_id>382-08-FB</org_study_id>
    <nct_id>NCT00748618</nct_id>
  </id_info>
  <brief_title>Vitamin D Replacement After Kidney Transplant</brief_title>
  <official_title>Vitamin D Replacement After Kidney Transplant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D deficiency accelerates vascular risk progression after kidney transplant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial will assess the following aims:

        1. Time to plateau vitamin D concentrations after initiating vitamin D supplements

        2. Safety of vitamin D replacement based on serum and urine calcium

        3. Effect of vitamin D on PTH concentration in individuals with elevated parathyroid
           hormone

        4. Effect of vitamin D on markers of insulin resistance and inflammation
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">March 2010</completion_date>
  <primary_completion_date type="Anticipated">October 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare efficacy and safety of two vitamin D supplements of these doses in normalizing vitamin D concentrations.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The ability of vitamin D to reduce parathyroid hormone concentration or change markers of vascular risk, insulin resistance, and/or inflammation, as well as its affect on urine calcium excretion.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Kidney Transplantation</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10,000 I.U. of vitamin D3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50,000 I.U. of vitamin D3</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3</intervention_name>
    <description>10,000 I.U./wk of vitamin D3 orally for 6 months</description>
    <arm_group_label>1</arm_group_label>
    <other_name>D3, vitamin D</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3</intervention_name>
    <description>50,000 I.U./wk of vitamin D3 orally for 6 months</description>
    <arm_group_label>2</arm_group_label>
    <other_name>D3, vitamin D</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Kidney transplant more than 6 months ago

          -  19 years or older

          -  25-OH vitamin D ≤30 ng/ml

        Exclusion Criteria:

          -  Estimated GFR&lt;30 ml/min/1.73m²

          -  Previous small bowel or lung transplant

          -  Pancreas transplant less than 6 months ago

          -  Cancer or any condition that would change their weight dramatically in the near
             future such as malabsorption

          -  Willing to return for testing every two months

          -  Women who are pregnant or &lt; 6 weeks postpartum

          -  Calcium &gt; 10.5 mg/dl

          -  Phosphate &gt; 4.8 mg/dl

          -  Taking 10,000 I.U. or more of vitamin D per week

          -  Drinking more than 2 alcohol drinks a day or 14 drinks per week

          -  History of parathyroid surgery

          -  Known granulomatous disease

          -  Magnesium &lt; 1.6 mg/dL

          -  Taking any seizure medication that affects vitamin D

          -  Taking zempler ® and/or Rocaltrol ®

          -  History of kidney stones

          -  Not on a stable dose of bisphosphonate for the past three months

          -  Planning on a pancreas transplant within the next year

          -  In any other research study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer L Larsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jillian M Witte, BSN</last_name>
    <phone>402-559-8553</phone>
    <email>jmwitte@unmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Terica L Hudson, BS</last_name>
    <phone>402-559-5077</phone>
    <email>thudson@unmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jillian M Witte, BSN</last_name>
      <phone>402-559-8553</phone>
      <email>jmwitte@unmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Terica L Hudson, BS</last_name>
      <phone>402-559-5077</phone>
      <email>thudson@unmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jennifer L Larsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <lastchanged_date>September 5, 2008</lastchanged_date>
  <firstreceived_date>September 4, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Jennifer Larsen, MD/ Int Med- DEM section chief</name_title>
    <organization>University of Nebraska Medical Center</organization>
  </responsible_party>
  <keyword>Kidney transplantation (KTX)</keyword>
  <keyword>Vitamin D deficiency</keyword>
  <keyword>Cardiovascular Disease (CVD)</keyword>
  <keyword>Vascular risk</keyword>
  <keyword>Parathyroid hormone (PTH)</keyword>
  <keyword>Carotid intima media thickness (CIMT)</keyword>
  <keyword>Insulin resistance (IR)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
